Figures
Abstract
In this study, we evaluated the effect of replacing dietary fiber with sodium butyrate on reproductive performance and antioxidant defense in a high fat diet during pregnancy by using a rat model. Eighty virgin female Sprague Dawley rats were fed one of four diets—(1) control diet (C group), (2) high fat + high fiber diet (HF group), (3) high-fat +5% sodium butyrate diet (SB group), and (4) HF diet + α-cyano-4-hydroxy cinnamic acid (CHC group)—intraperitoneally on days 8, 10, 12, 14, and 16 of gestation. SB and dietary fiber had similar effects on improving fetal number and reducing the abortion rate; however, the anti-oxidant capacity of maternal serum, placenta, and fetus was superior in the HF group than in the SB group. In comparison, CHC injection decreased reproductive performance and antioxidant defense. Both dietary fiber (DF) and SB supplementation had a major but different effect on the expression of anti-oxidant related genes and nutrient transporters genes. In summary, our data indicate that SB and DF showed similar effect on reproductive performance, but SB cannot completely replace the DF towards with respect to redox regulation in high-fat diet; and SB might influence offspring metabolism and health differently to DF.
Citation: Lin Y, Fang Z-f, Che L-q, Xu S-y, Wu D, Wu C-m, et al. (2014) Use of Sodium Butyrate as an Alternative to Dietary Fiber: Effects on the Embryonic Development and Anti-Oxidative Capacity of Rats. PLoS ONE 9(5): e97838. https://doi.org/10.1371/journal.pone.0097838
Editor: Xiaoying Wang, Massachusetts General Hospital, United States of America
Received: November 26, 2013; Accepted: April 24, 2014; Published: May 22, 2014
Copyright: © 2014 Lin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Inadequate fiber intake by humans is widespread, especially in developed countries [1]. Addition of dietary fiber to a high-fat, Western-style diet has beneficial effects on both maternal and fetal health [2]. Experimental investigations indicate that supplementing high-fat or low-fat diets with fiber might promote embryo survival and fetal development [3], [4] and reduce the oxidative stress of the organism [5], thus improving offspring health [6]. However, the mechanisms that cause maternal fiber intake to have a positive effect on the development and health of offspring have yet to be elucidated.
However, a large number of short chain fatty acids (SCFAs), including acetic, propionic, and butyric acid, are formed during bacterial fermentation in the gut after fiber intake. The colonic absorption of SCFAs might provide energy sources for colonocytes, liver and peripheral tissues [7]. The relative contribution of SCFAs to metabolic requirements differs across various mammals, being 10% in humans, 30–40% in typical hindgut fermenters, and 80% in forestomach fermenters [8]. In mammals, acetic, propionic, and butyric acid are the main components of SCFAs, with an energy supplement ranking of butyrate > propionate > acetate and butyric acid having the strongest nutritional effects [9], [10]. SCFAs that escape from colon cells enter the portal vein of the liver and can be converted into acetyl coenzyme A in the liver [11], which is then used in many biochemical reactions. This information indicates that SCFAs might contribute to the physiological effects of fibers in the body, especially butyrate. Previous studies have shown that butyrate improves the development of cloned porcine embryos in vitro [12], provides beneficial effects on the in vitro developmental competence of porcine somatic cell nuclear transfer [13], and activates genes involved in early development [14]. In vivo data indicate that orally administered sodium butyrate (SB) promotes the growth performance of weaning pigs [15], improves the intestinal health of humans [16], and delays the onset of diabetes in rats [17]. SB supplementation has a similar effect to wheat bran and guar gum on antioxidant property in diabetic rats [18]. Other studies have shown that diets supplemented with single SCFA or SCFA mixture may have a similar role to sugar-beet fiber in lowering the plasma cholesterol of rats [19] and alleviating rat colitis [20]. Therefore, it is plausible to hypothesize that the administration of butyrate might have the same effects as dietary fiber on maternal and fetal health. However, relatively few studies have reported the effect of maternal SB intake on embryo development, anti-oxidant capacity, and the gene expression of offspring.
Recent studies have demonstrated that the monocarboxylate transporter (MCT) is involved in the absorption of SCFAs across the apical membrane in both humans [21] and rats [22]. Fourteen MCT isoforms have been identified to date in mammals. MCT1 and MCT2 have very similar substrate specificities, but they differ with respect to affinity. MCT4, on the other hand, seems to be adapted for highly glycolytic cells, it is involved in the removal of lactic acid produced from glycolysis [23]. The expressions of MCT1, MCT4 and MCT9 mRNA increased significantly in mouse placenta from gestational day 11.5 and decreased at the end of gestation [24]. A significant increase in the expression levels of MCTs was observed in the rat adrenal gland after pectin supplementation [25], while butyrate and lactate increased the expression and activity of MCT1 in vitro [26], [27]. Thus, MCTs might be involved in the regulation of dietary fiber during reproduction. However, information remains limited about the effect of fiber intake on the expression of MCTs in the placenta or whether the inhibition of MCT expression alters the action induced by dietary fiber. Therefore, in this study, we aimed to determine whether supplementation with SB during pregnancy has a similar effect to fiber in improving fetal development and ameliorating maternal and placenta oxidative stress induced by a high-fat diet. In addition, we investigated how MCT expression during embryo development and reproduction is inhibited by injecting the MCT inhibitor a-cyano-4-hydroxycinnamic acid.
Materials and Methods
Animals and Diets
Eighty virgin female Sprague Dawley rats were offered a standard laboratory chow diet (20% protein) and water ad libitum until pregnancy was confirmed through the observation of vaginal plugs. Pregnant rats were allocated into 4 groups: (1) control diet (C), (2) high-fat + high-fiber diet (HF), (3) high-fat and sodium butyrate diet (SB, 5%, Purity ≥98.5% Sigma-Aldrich, St. Louis, MO, USA), and (4) high-fat and high-fiber diet with the injection of α-cyano-4-hydroxy-cinnamic acid (CHC, Sigma C2020, Purity ≥98%). The compositions of the experimental diets are presented in Table 1. Fat was composed of soybean oil, rapeseed oil, and pig lard, with fiber being provided by oat and wheat bran at a ratio of 1∶1. Fresh diets were made up on a weekly basis, and all diets were stored at 4°C. Animals were then housed separately at a temperature of 18–26°C on a 12-h light/12-h dark cycle, and they had free access to food and water until sample collection was performed on day 19.5 of pregnancy. All experimental protocols were approved by the Animal Care and Use Committee of the Sichuan Agricultural University, China, and were in accordance with the National Research Council's Guide for the Care and Use of Laboratory Animals.
Intraperitoneal CHC Injection
Embryo implantation occurs on about the 7th day of pregnancy in rats [28]. Rats in the CHC group were injected intraperitoneally with CHC on days 8, 10, 12, 14, and 16 of pregnancy, while the rats in the other groups were injected with saline on the same days, to serve as controls.
Blood and Tissue Sample Collection
Before sample collection, the rats were anesthetized in a sealed jar containing cotton wetted with 350 µl of isoflurane. Blood was drawn from the jugular vein and centrifuged at 4000 rpm for 10 min at 4°C for serum collection. Serum was stored at −20°C until analysis. The placenta and fetus were then immediately removed, weighed, and stored at −70°C until analysis. Part of the placenta and fetal liver were used for the histological examination. Fresh cecum content was collected from each rat and immediately processed for the SCFA analysis.
Measurements and Analytical Methods
Histological examination.
Small 0.5×0.5-cm segments of placental and fetal liver were cut and rinsed with ice-cold phosphate buffer saline. The segments were then fixed in 10% neutral buffered formalin, routinely processed, and stained with hematoxylin and eosin for histological examination.
SCFA analysis.
SCFA concentrations in the cecum contents were evaluated after extraction by using a previously described method [29]. Individual SCFAs were measured with a gas chromatograph (CP-3800, Varian, Lake Forest, CA, USA) equipped with a flame ionization detector and a capillary column (25 mm×0.32 mm, 0.3-µm film thickness; Varian Inc., USA). Helium was used as the carrier gas, and isobutyric acid was used as an internal standard. A standard SCFA mixture containing acetate, propionate, and butyrate was used for the calculation, and the results were expressed as mmol/g of sample.
Assay of malonaldehyde (MDA) and protein carbonyl concentrations.
Before the assays, placenta and fetal liver were homogenized in 1 ml of 0.15 M NaCl solution and centrifuged at 3000 rpm for 10 min at 4°C. Then, the supernatant was used for the analysis. The MDA concentrations in the serum, placenta, and fetus liver were quantified using the the thiobarbituric acid method [30], which is based on the reaction of MDA with thiobarbituric acid to form a pink chromogen. Protein carbonyl levels were determined from reactions with dinitrophenylhydrazine, using a commercially available kit (Oxiselect protein carbonyl ELISA; Cell Biolabs, San Diego, CA, USA), according to the manufacturer's instructions. Absorbance was measured at 370 nm, and concentrations were calculated using a molar extinction coefficient of 22,000 M/cm at 370 nm after the subtraction of the blank absorbance. Data were normalized to protein content and expressed as nmol/mg protein.
Assay of anti-oxidant related enzyme activity.
Glutathione peroxidase (GPx), catalase (CAT), total superoxide dismutase (T-SOD), Mn-SOD, and Cu-Zn SOD activity in maternal serum, placenta, and fetal liver were determined using a commercially available kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China), following the manufacturer's protocols. All assays were carried out in triplicate, using samples from six different rats per group. One unit of CAT activity was defined as 1 µM of H2O2 consumed per min, whereby 1 unit of GSH-Px was defined as the amount of enzyme necessary to oxidize 1 µmol/NADPH/min at pH 7.0 at 25°C and 1 unit of T-SOD activity was defined as the amount of sample protein capable of inhibiting the reduction of NBT by 50% of maximum inhibition. Mn-SOD activity was measured by the addition of 5 mmol/l NaCN to the reaction mixture, while Cu-Zn SOD was calculated by subtracting the Mn-SOD value from T-SOD. Enzyme-specific activities were expressed as units/mg of protein. Total protein concentration was determined using the Bradford method, and was expressed as mg/mL.
RNA preparation and quantitative real-time PCR of the placenta, fetal liver and fetal intestine.
The placenta, fetal liver, and intestine were removed from the animals and were immediately snap-frozen in liquid nitrogen and ground to a fine powder in a mortar pre-cooled with liquid nitrogen. Total RNA was extracted by Trizol reagent (TRIzol Reagent, Takara). All the procedures were performed according to the manufacturer's protocols. RNA expression was determined using quantitative real-time PCR. The genes listed in Table 2 were amplified by cDNA specific primers (Invitrogen, USA) on a Thermal Cycler (CHRMO4-TM Thermal Cycler; Bio-Rad, Hercules, CA, USA), according to the manufacturer's instructions and the following protocol: 95°C for 10 s, 40 cycles at 95°C for 5 s; and 60°C for 25 s. Melt curve conditions ranged from 65 to 95°C, reading every 0.5°C and holding for 5 s every 0.5°C (temperature change velocity: 0.5°C). The relative expression levels of gene expression were normalized to those of the eukaryotic house-keeping gene, β-actin.
Results
Reproduction Performance
Although the average daily feed intake and energy intake of SB group were significantly lower compared to all other groups (P<0.05, Table 3); however, the weight gain was not significant compared to the other groups (P>0.05). The fetal weight of the C group was significantly lower compared to the HF group (P<0.05), whereas there was no significant difference among the HF, SB, and CHC groups. Placental weight and placental efficiency were not affected by dietary energy types (P>0.05); however, the supplementation of SB increased the fetus number, which was a similar outcome to that observed in the HF group. Interestingly, abortion occurred more frequently in the CHC group; hence, it might contribute towards decreasing fetus number.
SCFA Concentration in Cecal Content
Dietary fiber intake significantly increased SCFA concentrations in the cecal contents compared to the C and SB group (P<0.05, Table 4). The concentrations of acetate, propionate, and butyrate in the cecal content were lower in the SB group than in the HF and CHC groups (P<0.05). Yet, the ratio of butyrate was higher in the SB group than in the HF and CHC groups (P<0.05), whereas the ratios of acetate and propionate were similar (P>0.05). Interestingly, CHC injection significantly decreased the butyrate ratio compared to the HF group (P<0.05).
MDA and Protein Carbonyl Content
Although MDA content was significantly higher in the maternal serum of the SB group than in that of the other groups (P<0.05, Table 5), there were no differences between the SB and HF groups in the placenta (P = 0.092) or fetal liver. In addition, similar protein carbonyl levels were obtained in the HF, SB and CHC groups for the maternal serum, placenta, and fetus; however, these levels were higher compared to the C group (P<0.05).
Antioxidant Enzymatic Activities
The GPx activity of the maternal serum, placenta, and fetal liver was lower in the SB group than in the HF group (P<0.05, Table 6). The maternal SB diet significantly decreased CAT activity in the maternal serum compared to the HF group (P<0.05). However, CAT activity in the placenta and fetal liver was similar in the SB, HF, and CHC groups (P<0.05), with no significant differences in the fetus liver among all 4 groups (P>0·05).
A significant decrease in Cu-Zn SOD activity, in parallel to an increase in Mn-SOD, of the maternal serum in the SB group was observed (P<0.05, Table 6). However, significantly lower T-SOD and Cu-Zn SOD activity was recorded in the placenta of the SB and CHC groups compared to the HF group (P<0.05), while similar T-SOD and Cu-Zn SOD activity was recorded in the fetus liver and the placenta of the SB group.
Placental and Fetus Liver Histology
The placental strucutre and integrity in the HF group was similar to the control group (Figure 1). In the SB and CHC groups, the placental trophoblasts were clearly malformed, and were partially necrotic. In addition, CHC injection had an adverse impact on placental integrity. Furthermore, more fat deposits were observed in the fetal liver of the SB and CHC groups than in that of the HF group. In addition, the HF group exhibited better cellular structure and morphology compared to the SB and CHC groups.
C, control group; HF, high-fat and high-fiber group; SB, high-fat and sodium butyrate group; CHC, HF diet with CHC injection group.
mRNA Expression Levels of MCT Genes in Maternal Cecum and Placenta
The mRNA expression levels of MCTs in the maternal intestine are presented in Figure 2A. Compared to the C group, DF or SB supplement significantly increased the mRNA levels of MCT1, MCT2 and MCT4 expression in the maternal intestine (P<0.05), but the mRNA levels of MCT1, MCT2 and MCT4 of maternal intestine in the SB group were not different from the DF group. CHC injection significantly inhibited the expression of MCT2 and MCT4 of maternal intestine compared to the HF group (P<0.05). The mRNA levels of MCT1 and MCT2 of placenta in the SB group were higher than those in the DF group (P<0.05), although the MCT4 expression in placenta was not detected at this stage.
Values are means, with standard deviations represented by vertical bars (n = 6). a, b, c Mean values with unlike letters were significantly different (P<0·05). MCT1, Monocarboxylic acid transporters 1; MCT2, Monocarboxylic acid transporters 2; MCT4, Monocarboxylic acid transporters 4. C, control group; HF, high-fat and high-fiber group; SB, high-fat and sodium butyrate group; CHC, HF diet with CHC injection group.
mRNA Expression of Placental Nutrient Transporter Genes
The mRNA expression levels of placental nutrient transporter related genes are shown in Figure 3. We found that, compared to the C group, the HF diet significantly up-regulated the mRNA levels of the glucose transporter genes 3 (Slc2a3) and sodium/glucose cotransporter 1 (Slc5a1), and the system A amino acid transporter gene, Slc38a2; however, this diet also down-regulated the mRNA levels of the cationic amino acid, Slc7a1 (P<0.05). In comparison, no significant difference was obtained between the HF and SB groups regarding mRNA expression levels. Compared to the HF group, Slc38a4 and peptide transporter 1 (PepT1) were significantly downregulated after CHC injection. Interestingly, the mRNA expression of Apolipoprotein A4 (Apoa4) increased when DF was replaced with SB, whereas the mRNA expression of fatty acid binding protein 2 (Fabp2) and Fabp3 was significantly downregulated after CHC injection (P<0.05; Figure 3).
Values are means, with standard deviations represented by vertical bars (n = 6). a, b, c Mean values with unlike letters were significantly different (P<0·05). Slc2a1, glucose transporter 1; Slc2a3, glucose transporter 3; Slc5a1, sodium/glucose cotransporter 1; Slc7a1, cationic amino acid transporter 1; Slc38a2, system A amino acid transporter gene Slc38a2; Slc38a4, system A amino acid transporter gene Slc38a4; PepT1, peptide transporter 1; Apoa4, Apolipoprotein A4; Fabp2, fatty acid binding protein 2; Fabp3, fatty acid binding protein 3. C, control group; HF, high-fat and high-fiber group; SB, high-fat and sodium butyrate group; CHC, HF diet with CHC injection group.
mRNA Expression of Fetus Liver and Intestine
The fatty acid metabolism-related genes mRNA expression levels of the fetal liver are presented in Figure 4. On day 19 of pregnancy, Apoa4 and Fabp3 in the fetus liver were upregulated after DF was replaced with SB (P<0.05). In addition, Apoa4 mRNA expression in the fetus liver of the HF group was noticeably higher compared to the C group (P<0.05). CHC injection downregulated the expression of all detected genes compared to the HF group (P<0.05).
Values are means, with standard deviations represented by vertical bars (n = 6). a, b, c Mean values with unlike letters were significantly different (P<0·05). Lipase, lipase; Apoa4, Apolipoprotein A4; Fabp2, fatty acid binding protein 2; Fabp3, fatty acid binding protein 3; Slc2a1, glucose transporter 1; Slc2a3, glucose transporter 3; Slc5a1, sodium/glucose cotransporter 1; Slc7a1, cationic amino acid transporter 1; Slc38a2, system A amino acid transporter gene Slc38a2; Slc38a4, system A amino acid transporter gene Slc38a4. C, control group; HF, high-fat and high-fiber group; SB, high-fat and sodium butyrate group; CHC, HF diet with CHC injection group.
The mRNA expression of the fetal intestine was affected by maternal dietary intake (Figure 4). Compared to the HF group, the SB group showed a significant up-regulation of Slc2a1 and Slc5a1 mRNA levels (P<0.05). The expression of Slc7a1, Slc38a2 and Slc38a4 in the fetal intestine of the HF group was similar to the C group (P>0.05); however, the expression of these genes was, to some extent, lower compared to the SB group. Fabp2 and Fabp3 mRNA expression was more upregulated by maternal SB intake compared to the HF group (P<0.05), with no significant difference between the HF and CHC groups (P>0.05).
mRNA Expression of Antioxidant-related Genes in Placenta and Fetus Liver
The mRNA expression levels of antioxidant genes in the placenta and fetus liver are presented in Figure 5. There was no significant difference among genes between the C and HF groups, with the exception of the CAT gene (Figure 5A). In comparison, the mRNA levels of placental thioredoxin-2 (Trx2), GPx1, and Cu-Zn SOD were higher in the HF group than in the SB group (P<0.05). There was no difference in the mRNA expression of CAT and Mn-SOD between the HF and SB groups (P>0.05). CHC injection caused all genes detected in the placenta to be repressed compared to the HF group. Meanwhile, the mRNA expressions of hypoxia-inducible factor 1-a (HIF-1α) and Bcl-2 in the SB group were significantly higher compared to the HF group ((Figure 5B, P<0.05), and was similar to the C group (P>0.05). However, the mRNA expression of HIF-1a, c-Jun N-terminal kinases (JNK1), P38, and Bcl-2 were observed to be downregulated in the CHC group (P<0.05).
Values are means, with standard deviations represented by vertical bars (n = 6). a,b,c Mean values with unlike letters were significantly different (P<0·05). Trx2, thioredoxin-2; GPx1, glutathione peroxidase 1; CAT, catalase; Cu,Zn-SOD, copper- and zinc-containing superoxide dismutase; Mn-SOD, manganese-containing superoxide dismutase; HIF-1a, hypoxia-inducible factor 1-a; JNK1, c-Jun N-terminal kinases; p38, p38; Bcl-2; Bax. C, control group; HF, high-fat and high-fiber group; SB, high-fat and sodium butyrate group; CHC, HF diet with CHC injection group.
As shown in Figure 5B, DF supplementation increased the mRNA expression of CAT, Mn-SOD, Trx2, HIF-1a, and JNK1 (P<0.05). Significantly higher mRNA expression of GPx1, CAT, and Cu-Zn SOD was observed in the fetal liver of the HF group, while the mRNA expression of Trx2, HIF-1a, and JNK1 was lower in the fetal liver of the HF group compared to the SB group (P<0.05). However, there was no significant difference in the mRNA levels of HIF-1α, Trx1, and Cu-Zn SOD between the C and HF groups. Interestingly, the mRNA expression of all genes in the fetal liver was observed to be downregulated, with the exception of GPx1, after CHC injection (P<0.05).
Discussion
SB is a short chain fatty acid that was originally identified as a product of the anaerobic bacterial fermentation of dietary fiber. This study confirmed that SB supplementation at 5% wt/wt in a high-fat diet has a similar effect to dietary fiber on embryo survival and abortion rate. In comparison, embryo survival decreased and the abortion rate increased when MCTs expression were inhibited by CHC injection, further validating the positive effects of fiber. However, research remains limited about the effects of SB and CHC injection on embryonic development. Previous studies have examined the effect of DF intake on reproductive performance and embryo development [4], [31]. Research has shown that the oral administration of SB increases the survival rate of diabetic rat pups by 8% [17]. SB treatment also increased the blastocyst formation rate of cloned pig embryos from 11.2% to 18.3% [12], while the survival of cultured embryonic stem cells also increased [14]. These results seem to suggest that SB might be e a substitute for DF towards improving reproductive performance, and appropriate SB intake in maternal model is needed to be explored in future.
The placenta is a very important organ for fetus survival and development, because it regulates the transport of nutrients and wastes. Our previous research demonstrated that a high-fat diet has an adverse effect on placental tissue integrity, with dietary fiber supplementation noticeably alleviating this phenomenon [3], [4]. In the present study, we confirmed that the supplementation of SB had a similar effect to HF at reducing the negative effect induced by a high-fat diet; however, this effect was inferior compared to DF. In particular, the placenta structure exhibited evident malformation and was partially necrotic after CHC injection, because MCTs were partially inhibited. This observation indicates that SCFA production may be involved in maintaining the integrity of placental tissue. In fact, the balance and imbalance of apoptosis and bax/bcl-2 affect the structure and function of the placenta [32]. The current study demonstrated that fiber supplementation of a high-fat diet decreased the expression of Bcl-2, whereas butyrate supplementation increased its expression, resulting in a higher Bcl-2/bax ratio. Recent studies have suggested that the up-regulation of Bcl-2 expression is responsible for an increase in the number of apoptotic renal cells [33]. In comparison, DF up-regulates the anti-apoptosis protein Bcl-2, and down-regulates the pro-apoptosis protein Bax [34], [35], resulting in a lower ratio of apoptosis [17]. Although it remains unclear how SB influences apoptosis, we can see that SB is not an efficient alternative to dietary fiber in maintaining placental structure integrity at this kind of model.
Of note, Bcl-2 exhibits antioxidant function and protects cells against mitochondrial oxidative stress [36]. In the current study, the expression of GPx1, Trx2, and Cu-Zn SOD in the placenta and GPx1, CAT, and Cu-Zn SOD in the fetal liver were lower in the SB group compared to the HF group; in contrast, Bcl-2 expression was higher in the SB group. This observed change in gene expression was supported by GPx1 and Cu-Zn SOD activity in the tissues and placenta structure after SB treatment. These results show that the anti-oxidant effect of SB is not as good as DF. It was previously reported that rats fed a high-fat diet suppressed Mn-SOD and Bcl-2 expression, leading to an increase in oxidative stress and the number of apoptotic renal cells [33]. DF supplementation of hamsters [35] or pregnant rats [4] ameliorated the oxidative stress induced by a high-fat diet. It has been previously demonstrated that butyrate and acetate reduce the induction of DNA damage by H2O2 in rat distal colon cells, whereas propionate was ineffective [37]. These findings imply the unique anti-oxidative effect of butyrate. In fact, butyrate beneficially influences oxidative stress in the colon of healthy humans [38], [39], in addition to alleviating oxidative stress induced by lipopolysaccharide in the intestinal cells [40] or streptozotocin diabetic rats [41], by changing the number of genes that is involved in radical scavenging [33], [39].
Reactive oxygen species (ROS) are potent inducers of various signaling pathways, encompassing the mitogen-activated protein kinases (MAPK) pathway and the Janus kinase/signal transducers and activators of transcription (JAK-STAT) pathway [42]. In the current study, HIF-1a mRNA was slightly upregulated in the placenta, while JNK1 and HIF-1a mRNA were slightly upregulated in the fetus liver. The supplementation of butyrate in a high-fat diet increases AMP kinase and p38 activity [43]. However, the effect of SB is eliminated after the knockout of JNK1, 2 stress-kinase genes [44]. Recent studies have found that β-hydroxybutyrate, which has a similar molecular structure to SB, suppresses oxidative stress in mice by increasing the transcription of encoding oxidative stress resistance factors, FOXO3A and MT2, and by increasing histone acetylation at the Foxo3a and Mt2 promoters [45]. Whether maternal SB intake has this effect on offspring requires future study.
Interestingly, although the SB supplementation of high-fat diets improves maternal, placental, and fetal antioxidant capacity, its effect is lower compared to various DFs, such as wheat bran and oat, which is consistent with the results of Kumar et al. [18]. This phenomenon is probably because wheat bran and oat are fermentable, producing butyrate, in addition to relatively high amounts of propionate and acetate. In fact, different DFs have different effects on metabolism because of different fermentable capacities and fermentation products [46]. In addition, fiber facilitates the excretion of dietary fat into the feces, which greatly reducing the oxidative stress induced by high-fat diets [47], whereas this effect is very limited for SB. Of note, it is possible that butyrate plays a major role in SCFA mechanisms, and it cannot completely substitute DF; however, information remains limited on this subject.
Compared to DF intake, SB has similar effects at up-regulating glucose and amino acid transporters; therefore, SB affects embryo growth and development. Research about DF and its metabolism, such as SB, on fetus development and transporters remains limited. In vitro cell culture, SB treatment had no effect on GLUT-1 mRNA expression, but upregulated GLUT2 mRNA expression by activating specific regions within the human GLUT2 promoter [48], [49]. The system A amino acid transporters, Slc38a2 and Slc384, mediate the transport of neutral amino acids, and are modulated by a butyrate-sensitive mechanism [50]. Meanwhile, butyrate increases PepT1 mRNA and protein expression and activity at the transcriptional level in colonic epithelial cells [51]. Of note, in the current study, the fatty acid transporters in the SB group were quite different to those of the HF and CHC groups in the placenta and fetus liver. This observation indicates that offspring might have a different fat metabolism. Apoa4 is an anorectic gene and involved in various activities, such as antioxidant activity and lipoproteins metabolism. Interesting, the expression of Apoa4 was up-regulated after SB addition which may alleviate the negative effect of high-fat diet induced obesity. In fact, butyrate alleviates metabolic stress in pregnant obese mice without any obvious toxicity to the fetus [17]. In butyrate-treated mice, the phosphorylation of AMP-activated protein kinase (AMPK) and p38, and the peroxisome proliferator-activated receptor (PPAR)-δ increased in the skeletal muscle, which alters the energy metabolism and, hence, the fat content (body weight) of obese mice was reduced [43]. Piglets born to sows that were supplemented with butyrate had 15% higher body weight, which was related to fatty acid metabolism [52]. In fact, the expression of lipoprotein lipase, fatty acid synthase, and PPAR-γ mRNA [53] was upregulated in propionate-infused sheep. SCFA-supplemented total parenteral nutrition up-regulates jejunal GLUT2 mRNA and ileal GLUT2 abundance, as well as increasing the jejunal uptake of L-glucose and lauric acid [54].
The current study indicates that the maternal intake of SB not only affects the expression of placental nutrient transporter gene, but also has a major effect on the gene expression of the fetal liver and intestine. Recent studies have shown that a total of 19400 genes respond to butyrate in a human colonic epithelial cell line [55], indicating that SB plays an important role in the regulation of gene expression and tissue homoeostasis. Although the effects of SB on gene expression have yet to be clarified, butyrate is an essential agent for determining the role of histone acetylation in chromatin structure and function; thus, SB might influence embryo development and gene expression [56]. Inhibition of histone deacetylases represents one of the mechanisms of GST activation by butyrate, which explains the possible role of butyrate on antioxidant related gene expression [57]. To the best of our knowledge, the imprint gene IGF2 plays an important role on placenta transporter expression and fetus growth, with butyrate being involved in the induction of Igf-2 activation and regulation of gene expression by histone modification [58].
In summary, the use of sodium butyrate as an alternative to dietary fiber in high-fat diets produces similar effects on reproduction performance. Maternal fiber intake was clearly superior to SB with respect to structure integrity of placenta and fetus liver, and redox regulation. In addition, DF regulated gene expression in the fetus liver and intestine very differently to SB. These results indicate that butyrate alone cannot completely replace dietary fiber in high-fat diet with regard to improving embryo development and anti-oxidant capacity.
Acknowledgments
I thank De Wu for outstanding assistance with conducting these experiments, Zheng-feng Fang, Lian-qiang Che and Sheng-yu Xu provided helpful comments that greatly improved the manuscript, and Cai-mei Wu, Xiu-qun Wu and Hua Li for assistance with experiment analysis.
Author Contributions
Conceived and designed the experiments: YL DW ZF. Performed the experiments: YL. Analyzed the data: YL. Contributed reagents/materials/analysis tools: YL LC SX CW XW. Wrote the paper: YL.
References
- 1. Clemens R, Kranz S, Mobley AR, Nicklas TA, Raimondi MP, et al. (2012) Filling America's fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods. J Nutr 142: 1390S–401S.
- 2. Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, et al. (2009) Health benefits of dietary fiber. Nutr Rev 67: 188–205.
- 3. Lin Y, Zhuo Y, Fang ZF, Che LQ, Wu D (2012) Effect of maternal dietary energy types on placenta nutrient transporter gene expressions and intrauterine fetal growth in rats. Nutrition 28: 1037–43.
- 4. Lin Y, Han XF, Fang ZF, Che LQ, Nelson J, et al. (2011) Beneficial effects of dietary fibre supplementation of a high-fat diet on fetal development in rats. Br J Nutr 106: 510–518.
- 5. Lecumberri E, Goya L, Mateos R, Alía M, Ramos S, et al. (2007) A diet rich in dietary fiber from cocoa improves lipid profile and reduces malondialdehyde in hypercholesterolemic rats. Nutrition 23: 332–341.
- 6.
Tzanetakou IP, Mikhailidis DP, Perrea DN (2011) Nutrition during pregnancy and the effect of carbohydrates on the offspring's metabolic profile: In search of the “perfect maternal diet”. Open Cardiovasc Med J 5103–5109.
- 7. Ichikawa H, Shineha R, Satomi S, Sakata T (2002) Gastric or rectal instillation of short-chain fatty acids stimulates epithelial cell proliferation of small and large intestine in rats. Dig Dis Sci 47: 1141–1146.
- 8. Bergman EN (1990) Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70: 567–590.
- 9. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80: 147–171.
- 10. Clausen MR, Mortensen PB (1994) Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. Gastroenterology 106: 423–432.
- 11. Rémésy C, Behr SR, Levrat MA, Demigne C (1992) Fiber fermentability in the rat cecum and its physiological consequences. Nutr Res 12: 1235–1244.
- 12. Das ZC, Gupta MK, Uhm SJ, Lee HT (2010) Increasing histone acetylation of cloned embryos, but not donor cells, by sodium butyrate improves their in vitro development in pigs. Cell Reprogram 12: 95–104.
- 13. Liu L, Liu Y, Gao F, Song G, Wen J, et al. (2012) Embryonic development and gene expression of porcine SCNT embryos treated with sodium butyrate. J Exp Zool B Mol Dev Evol 318: 224–234.
- 14. Goicoa S, Alvarez S, Ricordi C, Inverardi L, Domínguez-Bendala J (2006) Sodium butyrate activates genes of early pancreatic development in embryonic stem cells. Cloning Stem Cells 8: 140–149.
- 15. Le Gall M, Gallois M, Sève B, Louveau I, Holst JJ, et al. (2009) Comparative effect of orally administered sodium butyrate before or after weaning on growth and several indices of gastrointestinal biology of piglets. Br J Nutr 102: 1285–1296.
- 16. Fung KY, Cosgrove L, Lockett T, Head R, Topping DL, et al. (2012) A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 108: 820–831.
- 17. Li N, Hatch M, Wasserfall CH, Douglas-Escobar M, Atkinson MA, et al. (2010) Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak? J Pediatr Gastroenterol Nutr 51: 414–417.
- 18. Kumar AP, Mallikarjun Chougala, Nandini CD, Salimath PV (2010) Effect of butyric acid supplementation on serum and renal antioxidant enzyme activities in streptozotocin-induced diabetic rats. J Food Biochem 24: 15–30.
- 19. Hara H, Hara H, Haga S, Aoyama Y, Kiriyama S (1999) Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr 129: 942–948.
- 20. Andoh A, Bamba T, Sasaki M (1999) Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. J Parenter Enteral Nutr 23: S70–3.
- 21. Gill RK, Saksena S, Alrefai WA, Sarwar Z, Goldstein JL, et al. (2005) Expression and membrane localization of MCT isoforms along the length of the human intestine. Am J Physiol Cell Physiol 289: C846–852.
- 22. Borthakur A, Priyamvada S, Kumar A, Natarajan AA, Gill RK, et al. (2012) A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1. Am J Physiol Gastrointest Liver Physiol 303: G1126–1133.
- 23. Halestrap AP, Wilson MC (2012) The monocarboxylate transporter family–role and regulation. IUBMB Life 64: 109–119.
- 24. Nagai A, Takebe K, Nio-Kobayashi J, Takahashi-Iwanaga H, Iwanaga T (2010) Cellular expression of the monocarboxylate transporter (MCT) family in the placenta of mice. Placenta 31: 126–133.
- 25. Kirat D (2010) Effect of pectin feeding on monocarboxylate transporters in rat adrenal gland. J Comp Physiol B 180: 57–65.
- 26. Cuff MA, Lambert DW, Shirazi-Beechey SP (2002) Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J Physiol 539: 361–371.
- 27. Hashimoto T, Hussien R, Oommen S, Gohil K, Brooks GA (2007) Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis. FASEB J 21: 2602–2612.
- 28. Goodger AM, Rogers PA (1993) Uterine endothelial cell proliferation before and after embryo implantation in rats. J Reprod Fertil 99: 451–457.
- 29. Murase M, Kimura Y, Nagata Y (1995) Determination of portal short-chain fatty acids in rats fed various dietary fibers by capillary gas chromatography. J Chromatogr B Biomed Appl 664: 415–420.
- 30. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52: 302–310.
- 31. Che L, Feng D, Wu D, Fang Z, Lin Y, et al. (2011) Effect of dietary fibre on reproductive performance of sows during the first two parities. Reprod Domest Anim 46: 1061–1066.
- 32. Marzioni D, Mühlhauser J, Crescimanno C, Banita M, Pierleoni C, et al. (1998) BCL-2 expression in the human placenta and its correlation with fibrin deposits. Hum Reprod 13: 1717–1722.
- 33. Chung HW, Lim JH, Kim MY, Shin SJ, Chung S, et al. (2012) High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway. Nephrol Dial Transplant 27: 2213–2225.
- 34. Lopez-Oliva ME, Pozuelo MJ, Rotger R, Muñoz-Martinez E, Goni I (2013) Grape antioxidant dietary fibre prevents mitochondrial apoptotic pathways by enhancing Bcl-2 and Bcl-xL expression and minimising oxidative stress in rat distal colonic mucosa. Br J Nutr 109: 4–16.
- 35. Kuo DC, Hsu SP, Chien CT (2009) Partially hydrolyzed guar gum supplement reduces high-fat diet increased blood lipids and oxidative stress and ameliorates FeCl3-induced acute arterial injury in hamsters. J Biomed Sci 16: 15.
- 36. Zimmermann AK, Loucks FA, Schroeder EK, Bouchard RJ, Tyler KL, et al. (2007) Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem 282: 29296–304.
- 37. Abrahamse SL, Pool-Zobel BL, Rechkemmer G (1999) Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. Carcinogenesis 20: 629–34.
- 38. Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, et al. (2009) Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 28: 88–93.
- 39. Sauer J, Richter KK, Pool-Zobel BL (2007) Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells. J Nutr Biochem 18: 736–745.
- 40. Russo I, LucianI A, De Cicco P, Troncone E, Ciacci C (2012) Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One 7: e32841.
- 41. Sharma B, Singh N (2011) Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology (Berl) 215: 677–87.
- 42. Moslehi M, Yazdanparast R (2013) SK-N-MC cell death occurs by distinct molecular mechanisms in response to hydrogen peroxide and superoxide anions: involvements of JAK2-STAT3, JNK, and p38 MAP kinases pathways. Cell Biochem Biophys 66: 817–29.
- 43. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, et al. (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58: 1509–1517.
- 44. Zubova SG, Bykova TV, Zubova IuG, Romanov VS, Aksenov ND, et al. (2008) Sodium butyrate do not induce the program of premature senescence in transformants with JNK1,2 knockout. Tsitologiia 50: 964–971.
- 45. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, et al. (2013) Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339: 211–214.
- 46. Souza da Silva C, Bolhuis JE, Gerrits WJ, Kemp B, van den Borne JJ (2013) Effects of dietary fibers with different fermentation characteristics on feeding motivation in adult female pigs. Physiol Behav 110–111: 48–57.
- 47. Dgen L, Halas V, Tossenberger J, Szabób Cs, Babinszkyb L (2009) The impact of dietary fibre and fat levels on total tract digestibility of energy and nutrients in growing pigs and its consequence for diet formulation. Acta Agriculturae Scandinavica 59: 150–160.
- 48. Fernandez-Mejia C, Davidson MB (1993) Effect of sodium butyrate on glucose transport and glucose-phosphorylating enzymes in RIN-m5F cells. Pancreas 8: 589–96.
- 49. Mangian HF, Tappenden KA (2009) Butyrate increases GLUT2 mRNA abundance by initiating transcription in Caco2-BBe Cells. JPEN J Parenter Enteral Nutr 33: 6607–6617.
- 50. Boerner P, Saier MH Jr (1988) Effects of 5-azacytidine, sodium butyrate, and phorbol esters on amino acid transport system A in a kidney epithelial cell line, MDCK: evidence for multiple mechanisms of regulation. J Cell Physiol 137: 117–124.
- 51. Dalmasso G, Nguyen HT, YanY, Charrier-Hisamuddin L, Sitaraman SV, et al. (2008) Butyrate transcriptionally enhances peptide transporter pept1 expression and activity. PLoS ONE 3: e2476.
- 52. Lu H, SuS, Ajuwon KM (2012) Butyrate supplementation to gestating sows and piglets induces muscle and adipose tissue oxidative genes and improves growth performance. J Anim Sci 4: 430–442.
- 53. Lee SH, Hossner KL (2002) Coordinate regulation of ovine adipose tissue gene expression by propionate. J Anim Sci 80: 2840–2849.
- 54. Tappenden KA, Drozdowski LA, Thomson AB, McBurney MI (1998) Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 68: 118–125.
- 55. Daly K, Shirazi-Beechey SP (2006) Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA Cell Biol 25: 49–62.
- 56. Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. Nutr 133: 2485S–2493S.
- 57. Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, et al. (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 682: 39–53.
- 58. Shin JH, Li RW, Gao Y, Bickhart DM, Liu GE, et al. (2013) Butyrate induced igf2 activation correlated with distinct chromatin signatures due to histone modification. Gene Regul Syst Bio 7: 57–70.